Shares of Alexion ALXN spiked higher when Bloomberg reported that the pharmaceutical company will be working with Goldman Sachs GS on a potential takeover by Roche RHHBY.
Shares of Alexion jumped as high as $120.48, or 10.2 percent on the news. More than 2.5 million shares have already been traded, compared to the average of 2.03 million.
A previous offer from Roche was rejected, but Alexion will be working with Goldman Sachs in the case that Roche raises their offer to a level the pharmaceutical company finds appealing.
Bloomberg reports that Roche is interested in both the company’s blood medication and pipeline.
Analysts will likely review the company in the near future.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.